premargin

Element List	Explanation
Introduction	The Board of Directors of Dallah Healthcare Company, on 04-03-2026G (corresponding to 15-09-1447H), recommended to the Extraordinary General Assembly to increase the Company’s capital through issuance of bonus shares to the shareholders.
Date of Board Meeting	2026-03-04 Corresponding to 1447-09-15
Capital before increase	SAR 1,015,747,690
Capital after increase	SAR 1,218,897,230
Percentage of Capital increase	20 %
Number of shares before Capital increase	101574769
Number of shares after Capital increase	121889723
Reasons for the increase	The capital increase aims to strengthen the Company’s capital base in line with its total assets and enhance its financial position.
Number of Shares Granted per Exiting Share	One (1) bonus share for every five (5) shares held.
Nature and Value of Reserves Used in the Capitalization	SAR 93,614,972 will be funded through the statutory reserve and SAR109,534,568 from share premium.
Eligibility Date	Eligible Shareholders are Those Holding Shares in the Eligibility Date as per the Shareholders Registry at the Deposit Center at The End of The Second Working Day after Eligibility Date
Fractional Shares	In the event of fractional shares, such fractions shall be aggregated into one portfolio for all shareholders and sold at market price. The proceeds shall then be distributed to the shareholders entitled to the bonus shares, each in proportion to their respective entitlement, within a period not exceeding 30 days from the date the shares due to each shareholder are determined.
Approvals	This bonus share issuance is subject to obtaining the approvals of the competent authorities and the Extraordinary General Assembly for the capital increase and the number of shares granted.
Additional Information	The Company currently holds (471,821) treasury shares under the Employee Share Incentive Program. Subject to obtaining the required approvals for the proposed (20%) capital increase, the number of treasury shares will be adjusted proportionately to approximately (566,186) shares in line with the capital increase ratio. In case additional treasury shares are purchased between the date of this decision and the date of the Extraordinary General Meeting, bonus shares will be issued at the proposed (20%) rate against these additional treasury shares. Furthermore, the Extraordinary General Assembly will be requested to approve the amendment of the maximum limit of shares allocated to the Employee Share Incentive Program to become (1,200,000) shares instead of (1,000,000) shares, in line with the proposed capital increase.

Announcement of Dallah Healthcare Company regarding the Board of Directors’ recommendation to increase the Company’s capital through Issuance of Bonus Shares